| Powder: | Yes |
|---|---|
| Customized: | Customized |
| Certification: | GMP, ISO 9001, USP, BP |
| Suitable for: | Elderly, Adult |
| State: | Powder |
| Purity: | >98% |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier 
| Product Name: | Latanoprost |
| Synonyms: |
9ALPHA,11ALPHA,15R-TRIHYDROXY-17-PHENYL-18,19,20-TRINOR-PROST-5 Z-EN-1-OIC ACID, ISOPROPYL ESTER;9ALPHA, 11ALPHA, 15S-TRIHYDROXY- 17-PHENYL-18,19,20-TRINOR-PROS-5Z-EN-1-OIC ACID, ISOPROPYL ESTER; (1r-(1-alpha(z),2-beta(r*),3-alpha,5-alpha))--methylethyleste;7-(3,5-dihydroxy-2- (3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoicaci1;phxa41;xa41;isopropyl (5z,9α,11α,15r)-9,11,15-trihydroxy-17-phenyl-18,19,20-trinor-prost-5-en-1-oate; LATANAPROST |
| CAS: | 130209-82-4 |
| MF: | C26H40O5 |
| MW: | 432.59 |
| EINECS: | 634-172-9 |
Latanoprost ophthalmic solution is a medication administered into the eyes to control the progression of glaucoma or ocular hypertension by reducing intraocular pressure. It is a prostaglandin analogue (more specifically an analogue of prostaglandin F2α) that lowers the pressure by increasing the outflow of aqueous fluid from the eyes through the uvealsclearal tract. Latanoprost is an isopropyl ester prodrug, meaning it is inactive until it is hydrolyzed by esterases in the cornea to the biologically active acid.
Latanprost is a new type of anti-glaucoma drug, suitable for the topical treatment of primary open-angle glaucoma and patients with high intraocular pressure that are refractory to or tolerated by other drugs. Regression, chronic angle-closure glaucoma, quiescent uveitis and exfoliation syndrome also have good results.
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}